Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Janus Henderson Group PLC reported a 13.60% stake in Vistagen Therapeutics, Inc. (Schedule 13G)

Event Aug 29, 2025 · Filed Sep 8, 2025

Janus Henderson Group PLC reported a 13.60% stake in Vistagen Therapeutics, Inc., 4,165,767 shares, as a passive investor on Aug 29, 2025. Filed Sep 8, 2025 (Schedule 13G).

Stake
13.60%
Shares
4,165,767
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
JANUS HENDERSON GROUP PLC13.60%4,165,767
Janus Henderson Biotech Innovation Master Fund Ltd11.70%3,575,276

Source

View original at SEC

Related